IP Library Granted Patent US 12,362,047
Granted Patent B2
US 12,362,047 · App. 18/634,374 · Granted Jul 15, 2025

Liquid measurement systems, apparatus, and methods optimized with temperature sensing

Inventors: James White (Cambridge, MA); Richard Whalley (Cambridge, MA); Kevin Sihlanick (Cambridge, MA); Matthew Legrand (Cambridge, MA)
Assignee: Bigfoot Biomedical, Inc.
G16H10/60A61B5/14532A61B5/1495A61B5/157A61M5/3202G01F22/00G01F23/0015G01F23/2921G01F23/2961G01K13/02A61B2560/0252A61M2205/3306A61M2205/3368A61M2205/3379A61M2205/3553A61M2205/3561A61M2205/3592A61M2205/52A61M2205/581A61M2205/582A61M2205/583A61M2205/8212A61M2230/201G01K13/026G16H20/17
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,362,047
App. No.
18/634,374
Granted
Jul 15, 2025
Kind
B2
Abstract

An apparatus for measuring liquid volume in a container includes a plurality of light sources for emitting electromagnetic radiation (EMR) toward the container, a plurality of sensors optically coupleable to the plurality of light sources, each sensor of the plurality of sensors for detecting the EMR emitted by at least a portion of the plurality of light sources, a temperature sensor for measuring at least one temperature associated with a liquid in the container, and at least one processor for receiving data representative of the portion of the detected EMR from each of the plurality of sensors, comparing the at least one measured temperature to a temperature guideline to identify any temperature events associated with the received data; normalizing the received data based on any temperature events associated with the received data; and converting the normalized data into a signature representative of the EMR detected by the plurality of sensors.

Claims (63)

1. An apparatus for measuring liquid volume in a drug container, comprising:

at least one light source disposed and configured to emit electromagnetic radiation toward the drug container;

a plurality of sensors optically coupleable to the at least one light source, each sensor of the plurality of sensors disposed and configured to detect a portion of the electromagnetic radiation emitted by the at least one light source;

one or more temperature sensors disposed and configured to measure at least one temperature associated with a liquid in the drug container; and

at least one processor configured to receive data representative of the portion of the detected electromagnetic radiation from each of the plurality of sensors and the at least one measured temperature from the one or more temperature sensors, the at least one processor operable to:

convert the data into a signal signature including a plurality of values representative of the electromagnetic radiation detected by each sensor from the plurality of sensors, and

correct the signal signature based on the at least one measured temperature and one or more of a calibration temperature and background electromagnetic radiation, in which both the at least one measured temperature, and the one or more of the calibration temperature and the background electromagnetic radiation are used in determining one or more adjustments for the plurality of values of the signal signature.

2. The apparatus of claim 1 ,

wherein the at least one processor is further configured to receive, from the plurality of sensors, data representative of the background electromagnetic radiation detected by the plurality of sensors with the at least one light source in a dark state,

wherein the signal signature is corrected based on the at least one measured temperature and the background electromagnetic radiation.

3. The apparatus of claim 2 , wherein the at least one processor operable to:

convert the data representative of the background electromagnetic radiation into a background signature,

wherein the correction of the signal signature includes comparing the signal signature with the background signature, and

wherein the one or more adjustments for the plurality of values of the signal signature includes removing the background signature from the signal signature.

4. The apparatus of claim 1 , wherein

the at least one processor is configured to receive, from an independent temperature sensor of an external system, an external calibration temperature, the at least one processor operable to:

determine an offset that is a difference between the external calibration temperature and an internal temperature measured by the one or more temperature sensors,

adjust the at least one measured temperature by the offset,

wherein the signal signature is corrected based on the at least one measured temperature adjusted by the offset, and

wherein the one or more adjustments for the plurality of values of the signal signature includes the adjusting of the at least one measured temperature by the offset.

5. The apparatus of claim 4 , further comprising a communication interface configured to communicate with the external system, the at least one processor configured to receive the calibration temperature from the external system via the communication interface.

6. The apparatus of claim 1 ,

wherein the at least one processor operable to compare the at least one measured temperature to at least one temperature guideline to identify any temperature events associated with the received data,

wherein the correction of the signal signature is based on any temperature events associated with the received data and the one or more of the calibration temperature and the background electromagnetic radiation.

7. The apparatus of claim 6 , wherein the temperature event is at least one of a relationship and a difference between the at least one measured temperature and the at least one temperature guideline.

8. The apparatus of claim 6 , wherein the temperature guideline is specific to at least one of the apparatus, the drug container, and the liquid.

9. The apparatus of claim 1 , wherein the correction of the signal signature includes correcting the data representative of the electromagnetic radiation as detected by the plurality of sensors based on the at least one measured temperature, and the data corrected by the at least one measured temperature is converted into the signal signature.

10. The apparatus of claim 1 , wherein the at least one processor is configured to compare the signal signature as corrected to a plurality of reference signatures to determine a volume of the liquid in the drug container.

11. A method, comprising:

causing at least one light source to emit electromagnetic radiation toward a drug container;

detecting the emitted electromagnetic radiation through the drug container with a plurality of sensors;

measuring at least one temperature associated with a liquid in the drug container with a temperature sensor;

converting data from the plurality of sensors into a signal signature including a plurality of values representative of the electromagnetic radiation detected by each sensor from the plurality of sensors; and

correcting the signal signature based on the at least one measured temperature and one or more of a calibration temperature and background electromagnetic radiation, in which the correcting of the signal signature includes using both the at least one measured temperature, and the one or more of the calibration temperature and the background electromagnetic radiation in determining one or more adjustments for the plurality of values of the signal signature.

12. The method of claim 11 , further comprising:

detecting the background electromagnetic radiation with the at least one light source in a dark state with the plurality of sensors,

wherein the correcting of the signal signature is based on the at least one measured temperature and data representative of the background electromagnetic radiation detected by the plurality of sensors.

13. The method of claim 12 , further comprising:

converting the data representative of the background electromagnetic radiation into a background signature representative of the background electromagnetic radiation detected by each of the plurality of sensors,

wherein the correcting of the signal signature includes comparing the signal signature with the background signature, and

wherein the one or more adjustments for the plurality of values of the signal signature includes removing the background signature from the signal signature.

14. The method of claim 11 , further comprising:

detecting, with an independent temperature sensor of an external system, an external calibration temperature;

determine an offset that is a difference between the external calibration temperature and an internal temperature measured by the one or more temperature sensors;

adjusting the at least one measured temperature by the offset,

wherein the correcting of the signal signature is based on the at least one measured temperature adjusted by the offset, and

wherein the one or more adjustments for the plurality of values of the signal signature include the adjusting of the at least one measured temperature by the offset.

15. The method of claim 11 , further comprising:

comparing the at least one measured temperature to a temperature guideline to identify any temperature events associated with the received data,

wherein the correcting of the signal signature is based on the temperature events identified and the one or more of the calibration temperature and the background electromagnetic radiation.

16. The method of claim 11 , wherein the correcting of the signal signature includes correcting the data representative of the electromagnetic radiation based on both the at least one measured temperature, and one or more of a calibration temperature and background electromagnetic radiation, in which the data representative of the electromagnetic radiation as corrected is converted into the signal signature.

17. The method of claim 11 , further comprising:

comparing the signal signature as corrected to a plurality of reference signatures to determine the volume of the liquid in the drug container.

18. A health management system, comprising:

a drug delivery device including a drug reservoir; and

a dose measurement system configured to be removably coupleable to the drug delivery device, the dose measurement system including:

at least one light source disposed and configured to emit electromagnetic radiation toward the drug reservoir,

a plurality of sensors optically coupleable to the light source, each sensor of the plurality of sensors disposed and configured to detect a portion of the electromagnetic radiation emitted by the at least one light source;

one or more temperature sensors disposed and configured to measure at least one temperature associated with a liquid in the drug delivery device; and

at least one processor configured to receive data representative of the portion of the detected electromagnetic radiation from each of the plurality of sensors and the at least one measured temperature from the one or more temperature sensors, the at least one processor operable to:

convert the data into a signal signature including a plurality of values representative of the electromagnetic radiation detected by each sensor from the plurality of sensors, and

correct the signal signature based on the at least one measured temperature and one or more of a calibration temperature and background electromagnetic radiation, in which both the at least one measured temperature, and the one or more of the calibration temperature and the background electromagnetic radiation are used in determining one or more adjustments for the plurality of values of the signal signature, and the signature signal as corrected being representative of a volume of the liquid remaining in the drug reservoir.

19. The system of claim 18 , wherein the at least one processor is operable to compare the signal signature as corrected to a plurality of reference signatures to determine the volume of the liquid in the drug container, and the dose measurement system includes a display configured to present information to a user indicative of the volume of liquid remaining in the drug reservoir.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 28, 2025
From: WHALLEY, RICHARD; WHITE, JAMES; SIHLANICK, KEVIN; LEGRAND, MATTHEW
To: COMMON SENSING INC.
Reel/Frame 070959/0022 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 28, 2025
From: COMMON SENSING, INC.
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 071086/0377 →
Continuity (6)
Continuation 18328554 · Jun 2, 2023
Continuation 17455806 · Nov 19, 2021
Continuation 16280656 · Feb 20, 2019
Continuation 14816634 · Aug 3, 2015
Provisional Application 62032017 · Aug 1, 2014
Related Publication 20240312580A1 · Sep 19, 2024
References Cited (148)
US 4286646A · Tauber et al. · 1981 [cited by applicant]
US 4857738A · Myers et al. · 1989 [cited by applicant]
US 4904878A · Gipp et al. · 1990 [cited by applicant]
US 4952055A · Wyatt · 1990 [cited by applicant]
US 4956560A · Smith, Jr. et al. · 1990 [cited by applicant]
US 5065037A · Finney et al. · 1991 [cited by applicant]
US 5184510A · Rossman · 1993 [cited by applicant]
US 5303585A · Lichte · 1994 [cited by applicant]
US 5452076A · Schopper et al. · 1995 [cited by applicant]
US 5556002A · Green · 1996 [cited by applicant]
US 5569212A · Brown · 1996 [cited by applicant]
US 5593390A · Castellano et al. · 1997 [cited by applicant]
US 5606125A · Lyons et al. · 1997 [cited by applicant]
US 5628309A · Brown · 1997 [cited by applicant]
US 5720733A · Brown · 1998 [cited by applicant]
US 5748091A · Kim · 1998 [cited by applicant]
US 5782814A · Brown et al. · 1998 [cited by applicant]
US 5792117A · Brown · 1998 [cited by applicant]
US 5938642A · Burroughs et al. · 1999 [cited by applicant]
US 6068615A · Brown et al. · 2000 [cited by applicant]
US 6090473A · Yoshikawa et al. · 2000 [cited by applicant]
US 6110148A · Brown et al. · 2000 [cited by applicant]
US 6113578A · Brown · 2000 [cited by applicant]
US 6270455B1 · Brown · 2001 [cited by applicant]
US 6352523B1 · Brown et al. · 2002 [cited by applicant]
US 6452158B1 · Whatley et al. · 2002 [cited by applicant]
US 6505509B2 · Gualtieri · 2003 [cited by applicant]
US 6685678B2 · Evans et al. · 2004 [cited by applicant]
US 7049622B1 · Weiss · 2006 [cited by applicant]
US 7074209B2 · Evans et al. · 2006 [cited by applicant]
US 7115113B2 · Evans et al. · 2006 [cited by applicant]
US 7408632B2 · Moore et al. · 2008 [cited by applicant]
US 7498563B2 · Mandro et al. · 2009 [cited by applicant]
US 7710567B1 · Mentzer et al. · 2010 [cited by applicant]
US 7772008B2 · Curtis et al. · 2010 [cited by applicant]
US 8079245B1 · Owens et al. · 2011 [cited by applicant]
US 8197449B2 · Nielsen et al. · 2012 [cited by applicant]
US 8221356B2 · Enggaard et al. · 2012 [cited by applicant]
US 8348904B2 · Petersen · 2013 [cited by applicant]
US 8618485B1 · Lockhart · 2013 [cited by applicant]
US 8817258B2 · Whalley et al. · 2014 [cited by applicant]
US 9138091B2 · Zhao et al. · 2015 [cited by applicant]
US 9250111B2 · Whalley et al. · 2016 [cited by applicant]
US 9255830B2 · Whalley et al. · 2016 [cited by applicant]
US 9638564B2 · Whalley et al. · 2017 [cited by applicant]
US 9642968B2 · Whalley et al. · 2017 [cited by applicant]
US 10183120B2 · Sihlanick et al. · 2019 [cited by applicant]
US 10190901B2 · Whalley et al. · 2019 [cited by applicant]
US 10255991B2 · White et al. · 2019 [cited by applicant]
US 10258743B2 · Whalley et al. · 2019 [cited by applicant]
US 10684156B2 · Whalley et al. · 2020 [cited by applicant]
US 10695501B2 · Whalley et al. · 2020 [cited by applicant]
US 20010056258A1 · Evans · 2001 [cited by applicant]
US 20040079152A1 · Sorenson et al. · 2004 [cited by applicant]
US 20040089067A1 · Frank · 2004 [cited by applicant]
US 20050177137A1 · Kipfer · 2005 [cited by applicant]
US 20060154327A1 · Bachur, Jr. et al. · 2006 [cited by applicant]
US 20060178578A1 · Tribble et al. · 2006 [cited by applicant]
US 20070143062A1 · Memmott et al. · 2007 [cited by applicant]
US 20070213949A1 · Artiuch · 2007 [cited by applicant]
US 20080108885A1 · Colvin, Jr. · 2008 [cited by applicant]
US 20080113337A1 · Sakudo et al. · 2008 [cited by applicant]
US 20080316612A1 · Hyde et al. · 2008 [cited by applicant]
US 20090023222A1 · Wu et al. · 2009 [cited by applicant]
US 20090159654A1 · Grimard · 2009 [cited by applicant]
US 20090299279A1 · Richter · 2009 [cited by applicant]
US 20100030136A1 · Dacquay et al. · 2010 [cited by applicant]
US 20100080086A1 · Wright et al. · 2010 [cited by applicant]
US 20100134303A1 · Perkins · 2010 [cited by applicant]
US 20100213392A1 · Hatzav et al. · 2010 [cited by applicant]
US 20110102796A1 · Shang et al. · 2011 [cited by applicant]
US 20110184343A1 · Veit et al. · 2011 [cited by applicant]
US 20110257591A1 · Nelson Konen et al. · 2011 [cited by applicant]
US 20110270214A1 · Joergensen et al. · 2011 [cited by applicant]
US 20110292399A1 · Alphonse · 2011 [cited by applicant]
US 20110313395A1 · Krulevitch et al. · 2011 [cited by applicant]
US 20120234074A1 · Hagen · 2012 [cited by applicant]
US 20120268741A1 · Pommereau et al. · 2012 [cited by applicant]
US 20130030405A1 · Hartman et al. · 2013 [cited by applicant]
US 20130310756A1 · Whalley et al. · 2013 [cited by applicant]
US 20130331667A1 · Colvin, Jr. et al. · 2013 [cited by applicant]
US 20140130745A1 · Van Halsema et al. · 2014 [cited by applicant]
US 20140262918A1 · Chu · 2014 [cited by applicant]
US 20150115158A1 · Fu et al. · 2015 [cited by applicant]
US 20150362350A1 · Miller et al. · 2015 [cited by applicant]
US 20160030673A1 · White et al. · 2016 [cited by applicant]
US 20160061646A1 · Mestivier et al. · 2016 [cited by applicant]
US 20170232204A1 · Knapp et al. · 2017 [cited by applicant]
US 20170246399A1 · Forlani et al. · 2017 [cited by applicant]
US 20180050157A1 · Whalley et al. · 2018 [cited by applicant]
US 20180064881A1 · Whalley et al. · 2018 [cited by applicant]
US 20180299317A1 · Truong et al. · 2018 [cited by applicant]
US 20190110714A1 · O'Brien et al. · 2019 [cited by applicant]
US 20190137315A1 · Whalley et al. · 2019 [cited by applicant]
US 20190336695A1 · Sihlanick et al. · 2019 [cited by applicant]
US 20200023134A1 · Whalley et al. · 2020 [cited by applicant]
CN 1906485 · 2007 [cited by applicant]
CN 101262950 · 2008 [cited by applicant]
CN 102301207 · 2011 [cited by applicant]
CN 103354800 · 2013 [cited by applicant]
CN 105716680 · 2016 [cited by applicant]
DE 102006047537 · 2011 [cited by applicant]
EP 1382946 · 2004 [cited by applicant]
EP 1920793 · 2008 [cited by applicant]
JP 2000279515 · 2000 [cited by applicant]
JP 2010505475 · 2010 [cited by applicant]
JP 2013126532 · 2013 [cited by applicant]
WO 2010088591 · 2010 [cited by applicant]
WO 2010098929 · 2010 [cited by applicant]
WO 2011108225 · 2010 [cited by applicant]
WO 2011032960 · 2011 [cited by applicant]
WO 2011084713 · 2011 [cited by applicant]
WO 2012062843 · 2012 [cited by applicant]
WO 2012126975 · 2012 [cited by applicant]
Communication pursuant to Article 94(3) dated Mar. 22, 2019 from European Application No. 15826907.6, 5 pages. [cited by applicant]
Notice of Reasons for Rejection dated Apr. 9, 2019 from Japanese Application No. 2016-572816, w/English translation. [cited by applicant]
Notice of Reasons for Rejection dated Mar. 28, 2019 from Japanese Application No. 2015-514106, w/English translation, 14 pages. [cited by applicant]
Office Action dated Jan. 17, 2019 from Canadian Application No. 2,874,331, 4 pages. [cited by applicant]
Communication pursuant to Article 94(3) dated Jan. 31, 2018 issued by the European Patent Office from European Application No. 13793067.3, 6 pages. [cited by applicant]
Decision of Rejection dated Nov. 1, 2017 from Japanese Application No. 2015-514106, w/English translation, 13 pages. [cited by applicant]
Office Action dated Jul. 19, 2019 from Chinese Application No. 201580040532.0, w/English translation, 21 pages. [cited by applicant]
Extended European Search Report dated Jun. 7, 2016 from European Application No. 13793067.3, 21 pages. [cited by applicant]
Extended European Search Report dated Mar. 8, 2018 from European Application No. 15826907.6, 10 pages. [cited by applicant]
International Search Report and Written Opinion mailed Oct. 21, 2013 from International Application No. PCT/US2013/041982, 10 pages. [cited by applicant]
International Search Report and Written Opinion mailed Nov. 17, 2017 from International Application No. PCT/US2017/041982, 15 pages. [cited by applicant]
International Search Report and Written Opinion mailed Nov. 20, 2015 for International Application No. PCT/US2015/043417, 8 pages. [cited by applicant]
Notice of Reasons for Rejection dated Feb. 17, 2017 from Japanese Application No. 2015-514106 w/English translation, 15 pages. [cited by applicant]
Office Action dated Apr. 12, 2017 from Chinese Application No. 201380036003.4 w/English language translation, 15 pages. [cited by applicant]
Office Action dated Dec. 14, 2018 from Chinese Application No. 201580040532.0, w/English translation, 10 pages. [cited by applicant]
Office Action dated Jun. 28, 2016 from Chinese Application No. 201380036003.4 w/English language translation, 19 pages. [cited by applicant]
Office Action dated Mar. 27, 2018 from Chinese Application No. 20130036003.4 w/English translation, 7 pages. [cited by applicant]
Non-Final Office Action mailed Feb. 28, 2014 from U.S. Appl. No. 13/796,889, 10 pages. [cited by applicant]
Non-Final Office Actions mailed Jun. 10, 2015 from U.S. Appl. No. 14/334,181, 12 pages. [cited by applicant]
Non-Final Office Action mailed Jun. 15, 2016 from U.S. Appl. No. 14/982,650, 11 pages. [cited by applicant]
Non-Final Office Action mailed Jun. 17, 2016 from U.S. Appl. No. 14/982,668, 10 pages. [cited by applicant]
Non-Final Office Action mailed Dec. 22, 2017 from U.S. Appl. No. 15/464,466, 12 pages. [cited by applicant]
Non-Final Office Action mailed Jul. 25, 2018 from U.S. Appl. No. 15/477,444, 13 pages. [cited by applicant]
Non-Final Office Action mailed Jun. 11, 2019 for U.S. Appl. No. 16/235,286, 15 pages. [cited by applicant]
Non-Final Office Action mailed Jun. 29, 2018 from U.S. Appl. No. 14/816,634, 15 pages. [cited by applicant]
Non-Final Office Action mailed Feb. 14, 2018 from U.S. Appl. No. 15/649,224, 15 pages. [cited by applicant]
Non-Final Office Action mailed Aug. 29, 2019 from U.S. Appl. No. 16/209,580, 9 pages. [cited by applicant]
Appeal Decision dated Mar. 23, 2020 for Japanese Application No. 2015-514106, w/English translation, 24 pages. [cited by applicant]
Decision of Rejection dated Mar. 16, 2020 for Japanese Application No. 2016-572816, w/English translation, 9 pages. [cited by applicant]
Non-Final Office Action mailed Feb. 4, 2020 for U.S. Appl. No. 16/283,084, 11 pages. [cited by applicant]
Office Action dated Dec. 11, 2019 for Canadian Application No. 2,874,331, 4 pages. [cited by applicant]
Office Action dated Jul. 2, 2020 for Chinese Application No. 201910115230.5, with English translation, 18 pages. [cited by applicant]
Office Action dated Jul. 3, 2020 for Chinese Application No. 201780043779.7, with English translation, 30 pages. [cited by applicant]
Office Action issued for the Japanese patent application No. 2020-121999, Jun. 30, 2021, 7 pages including English translation. [cited by applicant]